Rhesoglobin

N/A

Report date: 2026/02/05 17:27:43

Base Information

Drug NameRhesoglobin
Drug Alias NameBP-SCIG
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionBlood group Rh(D) polypeptide inhibitors
TargetsBlood group Rh(D) polypeptide
Therapy Area/IndicationsPrimary Immunodeficiency Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraine
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiopharma Plasma LLC
China Registration ClassN/A

Develop Information

Active CompaniesBiopharma Plasma LLC
Inactive CompaniesN/A
Active IndicationsPrimary Immunodeficiency Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A